Scholarlink

Background <p>Liver abscess is a potentially life-threatening condition and differentiating between pyogenic (PLA) and amoebic liver abscess (ALA) can be challenging. Besides, increasing antimicrobial resistance and the lack of standardized guidelines complicate its management.</p> Methods <p>We conducted an observational study of adult individuals diagnosed with liver abscess at Vall d’Hebron University Hospital (Barcelona) from 2016 to 2020. Patients were classified as cryptogenic (CLA) or non-cryptogenic (NCLA) based on presumed pathophysiology. Data on demographics, microbiology, treatment and outcomes were collected. Multivariate logistic regression identified predictors of ALA, recurrence, and mortality.</p> Results <p>145 patients were included. Median age was 71 years; 74% were male. NCLA represented 72% of cases, mainly due to biliary tract disease (65%). Microbiological diagnosis was obtained in 117 (80%) cases, with Enterobacterales present in 75/103 (73%) of PLA. Enterobacterales showed high resistance rates, with amoxicillin-clavulanate resistance of 56% in NCLA vs. 29% in CLA, and to piperacillin-tazobactam 49% vs. 14%, respectively. ALA accounted for 14/40 (35%) of CLA. Migration or recent international travel was the only predictor (OR 11.2, <i>p</i> = 0.01), but 4/14 (29%) had no risk factors. Recurrence occurred in 7/92 (8%) NCLA cases. Thirty-day mortality for pyogenic abscesses was 14/106 (12%). Solid (OR 6.5, <i>p</i> = 0.003) and hematologic malignancies (OR 6.1, <i>p</i> = 0.043) were independently associated with early mortality.</p> Conclusion <p>CLA and NCLA differ significantly in presentation and microbiological isolations with high antimicrobial resistance among NCLA. In CLA cases, amoebic aetiology should be considered, even in the absence of classical risk factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Liver abscesses in Southern Europe: clinical and microbiological characterization of a retrospective cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Laura Pérez-Gallego,
  • David Martínez-Simón,
  • Miguel Villamarín,
  • Ibai Los-Arcos,
  • Fernando Salvador,
  • Lidia Goterris,
  • Oscar Len,
  • Joaquín Burgos,
  • Mayli Lung,
  • Vicenç Falcó,
  • Pau Bosch-Nicolau

摘要

Background

Liver abscess is a potentially life-threatening condition and differentiating between pyogenic (PLA) and amoebic liver abscess (ALA) can be challenging. Besides, increasing antimicrobial resistance and the lack of standardized guidelines complicate its management.

Methods

We conducted an observational study of adult individuals diagnosed with liver abscess at Vall d’Hebron University Hospital (Barcelona) from 2016 to 2020. Patients were classified as cryptogenic (CLA) or non-cryptogenic (NCLA) based on presumed pathophysiology. Data on demographics, microbiology, treatment and outcomes were collected. Multivariate logistic regression identified predictors of ALA, recurrence, and mortality.

Results

145 patients were included. Median age was 71 years; 74% were male. NCLA represented 72% of cases, mainly due to biliary tract disease (65%). Microbiological diagnosis was obtained in 117 (80%) cases, with Enterobacterales present in 75/103 (73%) of PLA. Enterobacterales showed high resistance rates, with amoxicillin-clavulanate resistance of 56% in NCLA vs. 29% in CLA, and to piperacillin-tazobactam 49% vs. 14%, respectively. ALA accounted for 14/40 (35%) of CLA. Migration or recent international travel was the only predictor (OR 11.2, p = 0.01), but 4/14 (29%) had no risk factors. Recurrence occurred in 7/92 (8%) NCLA cases. Thirty-day mortality for pyogenic abscesses was 14/106 (12%). Solid (OR 6.5, p = 0.003) and hematologic malignancies (OR 6.1, p = 0.043) were independently associated with early mortality.

Conclusion

CLA and NCLA differ significantly in presentation and microbiological isolations with high antimicrobial resistance among NCLA. In CLA cases, amoebic aetiology should be considered, even in the absence of classical risk factors.